ftInvstr
GUJTHEM · Healthcare ₹412.0 -3.04% Mkt Cap ₹4518 Cr

GUJTHEM

Healthcare Drug Manufacturers - Specialty & Generic
₹412.0
-3.04% today · 30d +14.54%
as of 2026-09-04
Price · Daily Candles
AI narrative is temporarily unavailable for GUJTHEM. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-03-31
REVENUE
₹44 Cr
+17.22% YoY
NET PROFIT
₹11 Cr
-9.23% YoY
OPM
44.91%
+0.43pp YoY
EPS
₹0.0
PE 95.83
Intrinsic value · DCF: N/A — Company is currently free-cash-flow negative (-2.7% of mktcap). DCF assumes a going concern generating positive cash flow; a meaningful intrinsic value can only be computed once FCF turns positive. Use the Strategy Fit and ML sections instead.
◇ Sector Position
PEERPEROCE %
GUJTHEM95.83
SUNPHARMA37.5721.44
DIVISLAB89.1821.56
ZYDUSLIFE24.6424.22
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
64
SCORE / 100
Overall
6-axis composite of the sections below.
Performance STRONG 75
Valuation STRETCHED 20
Growth MUTED 44
Profitability HIGH 100
Technicals NEUTRAL 58
Risk LOW 90
Key Stats
TTM PE
95.83
P/B
16.26
52W HIGH
₹479.0
OFF HIGH
-13.99%
DIV YIELD
0.16%
MKT CAP
₹4518 Cr
◉ Active Signals
MACDBullish2.9597
RSI(14)Bullish60.29
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold GUJTHEM and at what entry.

Sign up freeSign in